The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

The bioinformatics market is poised for substantial expansion, with its size projected to escalate from $3.12 billion in 2024 to an impressive $10.51 billion by 2035. This upward trajectory signifies a compound annual growth rate (CAGR) of 11.67%, underscoring the sector's growing importance in healthcare and scientific research. Notably, the demand for bioinformatics services is being driven...

Family health planning is about more than preparing for pregnancy or scheduling routine medical checkups. It involves making informed decisions that can benefit both current and future generations. One of the most valuable tools available today is genetic testing, which helps individuals and couples understand inherited health risks before they become medical challenges. Advances in genomic...

According to a newly published market research report by 24LifeSciences, the global predictive and presymptomatic testing market was valued at USD 5.8 billion in 2024 and is projected to reach USD 16.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.9% during the forecast period 20252032. Predictive and presymptomatic testing involves the analysis of genetic,...

Healthcare is no longer limited to treating diseases after symptoms appear. Modern medicine is increasingly focused on predicting health risks, preventing illness, and delivering treatments tailored to individual patients. At the center of this transformation is genetic testing, a technology that allows healthcare professionals to analyze genetic information and gain insights that were once...

The Molecular Cytogenetics Market is experiencing significant growth as the demand for advanced genetic testing continues to rise across clinical diagnostics, cancer research, and personalized medicine. Molecular cytogenetics combines molecular biology with cytogenetic techniques to identify chromosomal abnormalities at a higher resolution, enabling accurate diagnosis of genetic...

According to a newly published market research report by 24LifeSciences, global oligonucleotide pool market was valued at USD 1.25 billion in 2024 and is projected to reach USD 2.27 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period 2025–2032. Oligonucleotide pools, also known as oligo pools, are complex libraries comprising thousands...

The RNA editing market is experiencing a paradigm shift, largely fueled by technological innovations and the surging demand for personalized medicine. This sector is estimated to reach a market size of $28.48 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 6.00%. The burgeoning interest in genomic medicine is paving the way for novel RNA editing strategies,...